Martin Borch Jensen

Martin Borch Jensen is a prominent figure in the field of biogerontology, currently serving as Co-founder and Chief Scientific Officer at Gordian Biotechnology since October 2018, focusing on therapeutic screening for aging-related diseases. In addition, Martin holds positions on the Scientific Advisory Board of The Alliance for Longevity Initiatives and as President of Norn Group, a non-profit organization dedicated to advancing aging research. Prior experiences include a postdoctoral fellowship at the Buck Institute for Research on Aging, where research centered on mitochondrial stress and aging, and a Ph.D. from the National Institute on Aging/University of Copenhagen, with a focus on DNA repair mechanisms in the aging process. Martin's academic background includes a B.Sc. and M.S. in Nanotechnology from the University of Copenhagen and completion of the International Baccalaureate at Nørre Gymnasium.